Michael J Pishvaian (Michael Pishvaian)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Metastatic Colorectal Cancer

Top Venues

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Harshabad Singh, Joanne Xiu, Kevin S Kapner, Chen Yuan, Raja R Narayan, Matthew J Oberley, Alex P Farrell, Rishi Surana, Brandon M Huffman, Kimberley J Perez, James M Cleary, Alexander C Jordan, Andressa Dias Costa, Hannah L Williams, Srivatsan Raghavan, Benjamin A Weinberg, Michael J Pishvaian, Rachna T Shroff, Sanjay Goel, Stephanie K Dougan, Jonathan Andrew Nowak, David B Spetzler, George W Sledge, Brian M Wolpin, Andrew J Aguirre
Clinical and genomic features of classical and basal transcriptional subtypes in pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ida Micaily, Edik M Blais, Randi Carhart, Sophia S Lam, Steven J Cohen, Shawna J Cannaday, David Halverson, Lynn M Matrisian, Patricia DeArbeloa, Dzung Thach, Emanuel Petricoin, Michael J Pishvaian, Harish Lavu, Charles J Yeo, Atrayee Basu Mallick
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy. JCO precision oncology 7 (2023)
Ida Micaily, Edik M Blais, Randi Carhart, Sophia S Lam, Steven J Cohen, Shawna J Cannaday, David Halverson, Lynn M Matrisian, Patricia DeArbeloa, Dzung Thach, Emanuel Petricoin, Michael J Pishvaian, Harish Lavu, Charles J Yeo, Atrayee Basu Mallick
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy. JCO precision oncology 7 (2023)
Ida Micaily, Edik M Blais, Randi Carhart, Sophia S Lam, Steven J Cohen, Shawna J Cannaday, David Halverson, Lynn M Matrisian, Patricia DeArbeloa, Dzung Thach, Emanuel Petricoin, Michael J Pishvaian, Harish Lavu, Charles J Yeo, Atrayee Basu Mallick
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy. JCO precision oncology 7 (2023)
Ida Micaily, Edik M Blais, Randi Carhart, Sophia S Lam, Steven J Cohen, Shawna J Cannaday, David Halverson, Lynn M Matrisian, Patricia DeArbeloa, Dzung Thach, Emanuel Petricoin, Michael J Pishvaian, Harish Lavu, Charles J Yeo, Atrayee Basu Mallick
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy. JCO precision oncology 7 (2023)
Fanfan Xie, Ding Ding, Cong Lin, Dea Cunningham, Michael Wright, Ammar Asrar Javed, Nilofer S Azad, Valerie Lee, Ross Donehower, Ana De Jesus-Acosta, Dung T Le, Michael J Pishvaian, Eun Ji Shin, Anne Marie Lennon, Mouen Khashab, Vikesh Singh, Alison P Klein, Nicholas J Roberts, Amy Hacker-Prietz, Thomas McPhaul, Richard A Burkhart, William R Burns, Amol Narang, Atif Zaheer, Elliot K Fishman, Elizabeth D Thompson, Robert Anders, Xin Yu, Jin He, Christopher L Wolfgang, Lei Zheng, Dong-Bing Liu, Kui Wu, Daniel A Laheru
RAD51B Harbors Germline Mutations Associated With Pancreatic Ductal Adenocarcinoma. JCO precision oncology 6 (2022)
Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, Michael J Pishvaian, Yung-Jue Bang, Michael S Gordon, Ahmad Awada, D Ross Camidge, F Stephen Hodi, Grant A McArthur, Wilson H Miller, Andres Cervantes, Laura Q M Chow, Alexander M Lesokhin, Annemie Rutten, Mario Sznol, Deepali Rishipathak, Shang-Chiung Chen, Eric G Stefanich, Tony Pourmohamad, Maria Anderson, Jeong Kim, Mahrukh Huseni, Ina Rhee, Lillian L Siu
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Michael Cerniglia, Joanne Xiu, Axel Grothey, Michael J Pishvaian, Yasmine Baca, Jimmy J Hwang, John L Marshall, Ari M VanderWalde, Anthony Frank Shields, Heinz-Josef Lenz, Wolfgang Michael Korn, Mohamed Salem, Philip A Philip, Richard M Goldberg, Jia Zeng, Sunnie S Kim
Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers. Molecular cancer therapeutics (2021)
Christopher W Schultz, Grace A McCarthy, Teena Nerwal, Avinoam Nevler, James B DuHadaway, Matthew D McCoy, Wei Jiang, Samantha Z Brown, Austin Goetz, Aditi Jain, Valerie S Calvert, Vikalp Vishwakarma, Dezhen Wang, Ranjan Preet, Joel Cassel, Ross Summer, Hoora Shaghaghi, Yves Pommier, Simone A Baechler, Michael J Pishvaian, Talia Golan, Charles J Yeo, Emanuel F Petricoin, George C Prendergast, Joseph M Salvino, Pankaj K Singh, Dan A Dixon, Jonathan R Brody
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria. Molecular cancer therapeutics 20 (11) (2021)
E Gabriela Chiorean, Katherine A Guthrie, Philip A Philip, Elizabeth M Swisher, Florencia Jalikis, Michael J Pishvaian, Jordan D Berlin, Marcus S Noel, Jennifer M Suga, Ignacio Garrido-Laguna, Dana Backlund Cardin, Marc R Radke, Mai Duong, Shay Bellasea, Andrew M Lowy, Howard S Hochster
Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Neel D Trivedi, Samantha Armstrong, Hongkun Wang, Marion L Hartley, John Deeken, A Ruth He, Deepa Subramaniam, Heather Melville, Chris Albanese, John L Marshall, Jimmy Hwang, Michael J Pishvaian
A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies. Cancer medicine 10 (6) (2021)
Michael J Pishvaian, Hongkun Wang, Aiwu Ruth He, Jimmy J Hwang, Brandon G Smaglo, Sunnie S Kim, Benjamin A Weinberg, Louis M Weiner, John L Marshall, Jonathan R Brody
A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (19) (2020)
Janice M Mehnert, Emily Bergsland, Bert H O'Neil, Armando Santoro, Jan H M Schellens, Roger B Cohen, Toshihiko Doi, Patrick A Ott, Michael J Pishvaian, Igor Puzanov, Kyaw L Aung, Chiun Hsu, Christophe Le Tourneau, Antoine Hollebecque, Elena Élez, Kenji Tamura, Marlena Gould, Ping Yang, Karen Stein, Sarina A Piha-Paul
Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study. Cancer 126 (13) (2020)
Michael J Pishvaian, Rebecca S Slack, Wei Jiang, A Ruth He, Jimmy J Hwang, Amy Hankin, Karen Dorsch-Vogel, Divyesh Kukadiya, Louis M Weiner, John L Marshall, Jonathan R Brody
A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer. Cancer 124 (11) (2018)